Key Insights

Highlights

Treatment Research

3 treatments under study, led by Macrogol

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 1 trials

Late-Stage Pipeline

100%

1 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

1Total
Phase 4 (1)

Trial Status

Unknown1

Clinical Trials (1)

Showing 1 of 1 trials
NCT05920213Phase 4Unknown

Efficacy of L-Ornithine L-Aspartate and Polyethylene Glycol in Cirrhotic Patients With Overt Hepatic Encephalopathy

Showing all 1 trials

Research Network

Common Treatments

  • Macrogol1
  • Lactulose1
  • Lornithine Laspartate1

Active Sponsors

  • Jinnah Postgraduate Medical Centre1

Related Conditions

  • Hepatic Encephalopathy Stage 21
  • Hepatic Encephalopathy Stage 31

Activity Timeline